Menu

Filtros : "FCF004" "University of Alberta - Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, AB, Canada" Removidos: "Indexado no: BDENF" "FM-MOT" "Financiado pela FAPESB" "Financiado pelo FEDER" Limpar

Filtros

Refine with date range

  • 1

1 - 5 (5 records)

  • Artigo de periodico

    Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin (2024)

    Richter, Luca Maurice ; Al-Gousous, Jozef ; Araujo, Gabriel Lima Barros de ; Davies, Neal M ; Löbenberg, Raimar

    Source: Journal of Drug Delivery Science and Technology. Unidade: FCF

    Subjects: DEPRESSÃO, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RICHTER, Luca Maurice et al. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, v. 92, p. 1-14, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jddst.2023.105305. Acesso em: 24 maio 2024.

    • APA

      Richter, L. M., Al-Gousous, J., Araujo, G. L. B. de, Davies, N. M., & Löbenberg, R. (2024). Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin. Journal of Drug Delivery Science and Technology, 92, 1-14. doi:10.1016/j.jddst.2023.105305

    • NLM

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 maio 24 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305

    • Vancouver

      Richter LM, Al-Gousous J, Araujo GLB de, Davies NM, Löbenberg R. Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin [Internet]. Journal of Drug Delivery Science and Technology. 2024 ; 92 1-14.[citado 2024 maio 24 ] Available from: https://dx.doi.org/10.1016/j.jddst.2023.105305

  • Artigo de periodico

    Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development (2022)

    Yousef, Malaz ; Park, Chulhun; Le, Tyson S; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar

    Source: Dissolutiom Technologies. Unidade: FCF

    Subjects: FÁRMACOS, SISTEMA LINFÁTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 24 maio 2024.

    • APA

      Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86

    • NLM

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 maio 24 ] Available from: https://doi.org/10.14227/DT290222P86

    • Vancouver

      Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 maio 24 ] Available from: https://doi.org/10.14227/DT290222P86

  • Artigo de periodico

    Anti-inflammatory drug nanocrystals: state of art and regulatory perspective (2021)

    Macedo, Luiza Oliveira; Barbosa, Eduardo José ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci

    Source: European Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, NANOTECNOLOGIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MACEDO, Luiza Oliveira et al. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, v. 158, p. 1-15 art. 105654, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105654. Acesso em: 24 maio 2024.

    • APA

      Macedo, L. O., Barbosa, E. J., Löbenberg, R., & Bou-Chacra, N. A. (2021). Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, 158, 1-15 art. 105654. doi:10.1016/j.ejps.2020.105654

    • NLM

      Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654

    • Vancouver

      Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654

  • Artigo de periodico

    Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system (2017)

    Bou-Chacra, Nadia Araci ; Melo, Katherine Jasmine Curo; Morales, Ivan Andrés Cordova; Stippler, Erika S; Kesisoglou, Filippos; Yazdanian, Mehran; Löbenberg, Raimar

    Source: AAPS Journal. Unidade: FCF

    Subjects: SOLUBILIDADE, BIOFARMÁCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BOU-CHACRA, Nadia Araci et al. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system. AAPS Journal, v. 19, n. 4, p. 989-1001, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0085-5. Acesso em: 24 maio 2024.

    • APA

      Bou-Chacra, N. A., Melo, K. J. C., Morales, I. A. C., Stippler, E. S., Kesisoglou, F., Yazdanian, M., & Löbenberg, R. (2017). Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system. AAPS Journal, 19( 4), 989-1001. doi:10.1208/s12248-017-0085-5

    • NLM

      Bou-Chacra NA, Melo KJC, Morales IAC, Stippler ES, Kesisoglou F, Yazdanian M, Löbenberg R. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system [Internet]. AAPS Journal. 2017 ; 19( 4): 989-1001.[citado 2024 maio 24 ] Available from: https://doi.org/10.1208/s12248-017-0085-5

    • Vancouver

      Bou-Chacra NA, Melo KJC, Morales IAC, Stippler ES, Kesisoglou F, Yazdanian M, Löbenberg R. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system [Internet]. AAPS Journal. 2017 ; 19( 4): 989-1001.[citado 2024 maio 24 ] Available from: https://doi.org/10.1208/s12248-017-0085-5

  • Artigo de periodico

    Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system (2017)

    Monteiro, Lis Marie; Löbenberg, Raimar; Ferreira, Elizabeth Igne ; Cotrim, Paulo César; Kanashiro, Edite Hatsumi Yamashiro; Rocha, Mussya; Chung, Man Chin; Bou-Chacra, Nadia Araci

    Source: International Journal of Antimicrobial Agents. Unidades: FCF, FM, IMT

    Subjects: LEISHMANIA, MACRÓFAGOS, NANOPARTÍCULAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MONTEIRO, Lis Marie et al. Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system. International Journal of Antimicrobial Agents, v. 50, n. 1, p. 88-92, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ijantimicag.2017.01.033. Acesso em: 24 maio 2024.

    • APA

      Monteiro, L. M., Löbenberg, R., Ferreira, E. I., Cotrim, P. C., Kanashiro, E. H. Y., Rocha, M., et al. (2017). Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system. International Journal of Antimicrobial Agents, 50( 1), 88-92. doi:10.1016/j.ijantimicag.2017.01.033

    • NLM

      Monteiro LM, Löbenberg R, Ferreira EI, Cotrim PC, Kanashiro EHY, Rocha M, Chung MC, Bou-Chacra NA. Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system [Internet]. International Journal of Antimicrobial Agents. 2017 ; 50( 1): 88-92.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijantimicag.2017.01.033

    • Vancouver

      Monteiro LM, Löbenberg R, Ferreira EI, Cotrim PC, Kanashiro EHY, Rocha M, Chung MC, Bou-Chacra NA. Targeting Leishmania amazonensis amastigotes through macrophage internalisation of a hydroxymethylnitrofurazone nanostructured polymeric system [Internet]. International Journal of Antimicrobial Agents. 2017 ; 50( 1): 88-92.[citado 2024 maio 24 ] Available from: https://doi.org/10.1016/j.ijantimicag.2017.01.033
  • 1

1 - 5 (5 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024